FGF2 and cataract: Taken together, our data from in vitro human LECs, in vivo mouse ASC model, as well as human cataract patients consistently support the idea that targeting SDC-4 can effectively suppress bFGF-induced proliferation and migration, as well as integrin-mediated adhesion of LECs.